GIOVANNONI, ROBERTO
GIOVANNONI, ROBERTO
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Current Therapeutical Approaches Targeting Lipid Metabolism in NAFLD
2023 Vitulo, M; Gnodi, E; Rosini, G; Meneveri, R; Giovannoni, R; Barisani, D
Endothelial Effects of Simultaneous Expression of Human HO-1, E5NT, and ENTPD1 in a Mouse
2023 Mierzejewska, P; Di Marzo, N; Zabielska-Kaczorowska, M; Walczak, I; Slominska, E; Lavitrano, M; Giovannoni, R; Kutryb-Zajac, B; Smolenski, R
Tumor Microenvironment and Immune Escape in the Time Course of Glioblastoma
2022 Virtuoso, A; De Luca, C; Cirillo, G; Riva, M; Romano, G; Bentivegna, A; Lavitrano, M; Papa, M; Giovannoni, R
Inhibition of plasminogen/plasmin system retrieves endogenous nerve growth factor and adaptive spinal synaptic plasticity following peripheral nerve injury
2021 Virtuoso, A; Colangelo, A; Korai, S; Izzo, S; Todisco, A; Giovannoni, R; Lavitrano, M; Papa, M; Cirillo, G
p65BTK Is a Novel Biomarker and Therapeutic Target in Solid Tumors
2021 Grassilli, E; Cerrito, M; Bonomo, S; Giovannoni, R; Conconi, D; Lavitrano, M
The glioblastoma microenvironment: Morphology, metabolism, and molecular signature of glial dynamics to discover metabolic rewiring sequence
2021 Virtuoso, A; Giovannoni, R; De Luca, C; Gargano, F; Cerasuolo, M; Maggio, N; Lavitrano, M; Papa, M
BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers
2020 Lavitrano, M; Ianzano, L; Bonomo, S; Cialdella, A; Cerrito, M; Pisano, F; Missaglia, C; Giovannoni, R; Romano, G; Mclean, C; Voest, E; D'Amato, F; Noli, B; Ferri, G; Agostini, M; Pucciarelli, S; Helin, K; Leone, B; Canzonieri, V; Grassilli, E
Sperm-Mediated Genetic Modifications
2020 Lavitrano, M; Farina, L; Cerrito, M; Giovannoni, R
CHRNA2 and nocturnal frontal lobe epilepsy: Identification and characterization of a novel loss of function mutation
2019 Villa, C; Colombo, G; Meneghini, S; Gotti, C; Moretti, M; Ferini-Strambi, L; Chisci, E; Giovannoni, R; Becchetti, A; Combi, R
p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma
2019 Giordano, F; Vaira, V; Cortinovis, D; Bonomo, S; Goedmakers, J; Brena, F; Cialdella, A; Ianzano, L; Forno, I; Cerrito, M; Giovannoni, R; Ferri, G; Tasciotti, E; Vicent, S; Damarco, F; Bosari, S; Lavitrano, M; Grassilli, E
Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype
2019 Sala, L; Cirillo, G; Riva, G; Romano, G; Giussani, C; Cialdella, A; Todisco, A; Virtuoso, A; Cerrito, M; Bentivegna, A; Grassilli, E; Ardizzoia, A; Bonoldi, E; Giovannoni, R; Papa, M; Lavitrano, M
The 1ALCTL and 1BLCTL isoforms of Arg/Abl2 induce fibroblast activation and extra cellular matrix remodelling differently
2019 Torsello, B; De Marco, S; Bombelli, S; Chisci, E; Cassina, V; Corti, R; Bernasconi, D; Giovannoni, R; Bianchi, C; Perego, R
A novel KCNJ2 mutation identified in an autistic proband affects the single channel properties of Kir2.1
2018 Binda, A; Rivolta, I; Villa, C; Chisci, E; Beghi, M; Cornaggia, C; Giovannoni, R; Combi, R
APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe −/− atherosclerotic mice
2018 Romano, G; Reggi, S; Kutryb-Zajac, B; Facoetti, A; Chisci, E; Pettinato, M; Giuffrè, M; Vecchio, F; Leoni, S; De Giorgi, M; Avezza, F; Cadamuro, M; Crippa, L; Leone, B; Lavitrano, M; Rivolta, I; Barisani, D; Smolenski, R; Giovannoni, R
CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells
2018 Lupia, M; Angiolini, F; Bertalot, G; Freddi, S; Sachsenmeier, K; Chisci, E; Kutryb-Zajac, B; Confalonieri, S; Smolenski, R; Giovannoni, R; Colombo, N; Bianchi, F; Cavallaro, U
Innovative and Efficient Oral Delivery Method of APOA-1Milano Muteins Which Retain Anti-Atherosclerotic and Anti-Inflammatory Properties
2018 Giovannoni, R; Facoetti, A; Chisci, E; Reggi, S; Kutryb-Zajac, B; Bombelli, S; Di Marzo, N; Farina, L; Bianchi, C; Perego, R; Avezza, F; Cadamuro, M; Crippa, L; Lavitrano, M; Bentivegna, A; Leone, B; Rivolta, I; Barisani, D; Smolenski, R; Romano, G
Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study.
2018 Cerrito, M; De Giorgi, M; Pelizzoni, D; Bonomo, S; Digiacomo, N; Scagliotti, A; Bugarin, C; Gaipa, G; Grassilli, E; Lavitrano, M; Giovannoni, R; Bidoli, P; Cazzaniga, M
Resveratrol impairs glioma stem cells proliferation and motility by modulating the wnt signaling pathway
2017 Cilibrasi, C; Riva, G; Romano, G; Cadamuro, M; Bazzoni, R; Butta, V; Paoletta, L; Dalpra', L; Strazzabosco, M; Lavitrano, M; Giovannoni, R; Bentivegna, A
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro
2017 Chisci, E; De Giorgi, M; Zanfrini, E; Testasecca, A; Brambilla, E; Cinti, A; Farina, L; Kutryb Zając, B; Bugarin, C; Villa, C; Grassilli, E; Combi, R; Gaipa, G; Cerrito, M; Rivolta, I; Smolenski, R; Lavitrano, M; Giovannoni, R
Thyrospheres from B-CPAP Cell Line with BRAF and TERT promoter mutations have Different Functional and Molecular Features than Parental Cells
2017 Caria, P; Pillai, R; Dettori, T; Frau, D; Zavattari, P; Riva, G; Romano, G; Pani, F; Bentivegna, A; Giovannoni, R; Pagni, F; Sogos, V; Vanni, R